Kidney Function, Kidney Replacement Therapy, and Mortality in Men and Women

Autor: Sebastian Hödlmoser, Juan Jesus Carrero, Amelie Kurnikowski, Edouard L. Fu, Oskar Swartling, Wolfgang C. Winkelmayer, Eva S. Schernhammer, Manfred Hecking

Publikováno v: Kidney International Reports, Vol 7, Iss 3, Pp 444-454 (2022)

Introduction: Women are more likely to have chronic kidney disease (CKD), compared with men, yet they are less likely to receive dialysis. Whether this sex disparity, which has predominantly been observed in nephrology-referred or CKD-specific cohort

Externí odkaz: https://doaj.org/article/11b4767431dd4eee82550b9803a5f4bd

Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care

Autor: Patrick Bidulka, Edouard L. Fu, Clémence Leyrat, Fotini Kalogirou, Katherine S. L. McAllister, Edward J. Kingdon, Kathryn E. Mansfield, Masao Iwagami, Liam Smeeth, Catherine M. Clase, Krishnan Bhaskaran, Merel van Diepen, Juan-Jesus Carrero, Dorothea Nitsch, Laurie A. Tomlinson

Publikováno v: BMC Medicine, Vol 18, Iss 1, Pp 1-11 (2020)

Abstract Background The safety of restarting angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) after acute kidney injury (AKI) is unclear. There is concern that previous users do not restart ACEI/ARB despite on

Externí odkaz: https://doaj.org/article/0fe9886e50034fe48ce305184b3d26d7

Correction to: Biomarkers in clinical epidemiology studies.

Publikováno v: Clinical Kidney Journal. Sep2024, Vol. 17 Issue 9, p1-1. 1p.

Defining measures of kidney function in observational studies using routine health care data

Autor: Juan Jesus Carrero, Edouard L. Fu, Søren V. Vestergaard, Simon Kok Jensen, Alessandro Gasparini, Viyaasan Mahalingasivam, Samira Bell, Henrik Birn, Uffe Heide-Jørgensen, Catherine M. Clase, Faye Cleary, Josef Coresh, Friedo W. Dekker, Ron T. Gansevoort, Brenda R. Hemmelgarn, Kitty J. Jager, Tazeen H. Jafar, Csaba P. Kovesdy, Manish M. Sood, Bénédicte Stengel, Christian F. Christiansen, Masao Iwagami, Dorothea Nitsch

Publikováno v: Carrero, J J, Fu, E L, Vestergaard, S V, Jensen, S K, Gasparini, A, Mahalingasivam, V, Bell, S, Birn, H, Heide-Jørgensen, U, Clase, C M, Cleary, F, Coresh, J, Dekker, F W, Gansevoort, R T, Hemmelgarn, B R, Jager, K J, Jafar, T H, Kovesdy, C P, Sood, M M, Stengel, B, Christiansen, C F, Iwagami, M & Nitsch, D 2023, ' Defining measures of kidney function in observational studies using routine health care data : methodological and reporting considerations ', Kidney International, vol. 103, no. 1, pp. 53-69 . https://doi.org/10.1016/j.kint.2022.09.020

The availability of electronic health records and access to a large number of routine measurements of serum creatinine and urinary albumin enhance the possibilities for epidemiologic research in kidney disease. However, the frequency of health care u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f93572b384ff52df11d0f90f787397a
http://www.scopus.com/inward/record.url?scp=85142190301&partnerID=8YFLogxK

Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project

Autor: Jim, Alkas, Alessandro, Bosi, Arvid, Sjölander, Peter, Barany, Carl-Gustaf, Elinder, Edouard L, Fu, Juan Jesus, Carrero

Publikováno v: Journal of Nephrology. 36:705-711

Introduction Little is known about the comparative effects of sodium glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP1-RA), or dipeptidyl peptidase-4 inhibitors (DPP-4i) on the risk of acute kidney injury (A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3972b2ebe400726f79378e720fafcdc
https://doi.org/10.1007/s40620-022-01505-8